Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level908 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (460)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02009176 | Laparoscope Anatomical and Aon-anatomical Hepatectomy | unknown | N/A | 110 | Shuguo Zheng, MDOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT05118451 | A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC | unknown | N/A | 420 | Zhujiang HospitalOTHER | 1 | Feb 10, 2022 | clinicaltrials |
| NCT05233358 |
| HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure |
| unknown |
| N/A |
| 176 |
| The Central Hospital of Lishui CityOTHER |
| 0 |
| Feb 10, 2022 |
| clinicaltrials |
| NCT05160740 | Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer(ICGMFITinPLC) | unknown | N/A | 348 | Zhujiang HospitalOTHER | 1 | Feb 4, 2022 | clinicaltrials |
| NCT05162898 | Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma. | unknown | N/A | 90 | Henan Cancer HospitalOTHER_GOV | 0 | Jan 27, 2022 | clinicaltrials |
| NCT03109262 | Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors | completed | N/A | 42 | Stanford UniversityOTHER | 1 | Jan 10, 2022 | clinicaltrials |
| NCT05068076 | Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC | completed | N/A | 21 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Dec 21, 2021 | clinicaltrials |
| NCT03731910 | Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE | unknown | N/A | 35 | Seoul National University HospitalOTHER | 1 | Dec 17, 2021 | clinicaltrials |
| NCT03796819 | Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma(LND for ICC) | completed | N/A | 260 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT04847726 | Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma | completed | N/A | 110 | Seoul National University HospitalOTHER | 1 | Dec 7, 2021 | clinicaltrials |
| NCT03113955 | STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma | completed | N/A | 109 | Varian Medical SystemsINDUSTRY | 1 | Dec 1, 2021 | clinicaltrials |
| NCT05121571 | The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study | completed | N/A | 114 | Sun Yat-sen UniversityOTHER | 1 | Nov 26, 2021 | clinicaltrials |
| NCT03926039 | Sharing Decision-making Program for HCC Patients Treatment Decisions | completed | N/A | 70 | National Taipei University of Nursing and Health SciencesOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT05017922 | Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma | completed | N/A | 89 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT05032014 | Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer | unknown | N/A | 46 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT01141478 | Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria(HCC) | terminated | N/A | 8 | Loma Linda UniversityOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT03644173 | Personal Resilience Empowerment Program Study | completed | N/A | 37 | Hackensack Meridian HealthOTHER | 1 | Oct 15, 2021 | clinicaltrials |
| NCT01387503 | Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging | completed | N/A | 74 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 11, 2021 | clinicaltrials |
| NCT04443049 | To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | unknown | N/A | 170 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT01642446 | Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension | completed | N/A | 160 | Sun Yat-sen UniversityOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT03591705 | TACE-HAIC vs. HAIC for Potentially Resectable HCC | unknown | N/A | 240 | Sun Yat-sen UniversityOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04531228 | TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial(Thalen) | unknown | N/A | 60 | Yunfei YuanOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT05053386 | Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma | unknown | N/A | 186 | Zhejiang Cancer HospitalOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04891874 | Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI | completed | N/A | 76 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT05038397 | A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial(Therasphere) | completed | N/A | 30 | MedicalExcellenceOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT04455932 | HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation | recruiting | N/A | 476 | Concord Repatriation General HospitalOTHER | 2 | Sep 8, 2021 | clinicaltrials |
| NCT02329106 | Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02332551 | Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder | completed | N/A | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02333773 | Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor Emboli(IRE) | completed | N/A | 15 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02352935 | Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function | completed | N/A | 15 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT02921139 | Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)(TASABR) | unknown | N/A | 120 | Dalin Tzu Chi General HospitalOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT05009550 | ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation | unknown | N/A | 30 | TC Erciyes UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04267575 | Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites | unknown | N/A | 20 | Jerome Canady, M.D.OTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT02774161 | B-mode Ultrasound Imaging in Detecting Early Liver Cancer | completed | N/A | 45 | Stanford UniversityOTHER | 1 | Aug 3, 2021 | clinicaltrials |
| NCT04511793 | Hepatic Artery Infusion (HAI) Program at Duke University | withdrawn | N/A | 0 | Michael Lidsky, M.D.OTHER | 0 | Jul 19, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04961138 | Pre-operative Neoadjuvant Therapy Combined With Surgery for Treating Stage III Hepatocellular Carcinoma | unknown | N/A | 164 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Jul 14, 2021 | clinicaltrials |
| NCT04955119 | Fusion Imaging Contrast-enhanced Ultrasound LI-RADS | unknown | N/A | 132 | Tianjin Third Central HospitalOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT04269499 | Real-time Imaging of Holmium Radioembolization: a Feasibility Study(Emeritus) | completed | N/A | 6 | Radboud University Medical CenterOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT02964260 | RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma | unknown | N/A | 410 | Sun Yat-sen UniversityOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT04517227 | The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD) | unknown | N/A | 30 | Fudan UniversityOTHER | 0 | May 3, 2021 | clinicaltrials |
| NCT02556619 | Randomized Control Trial (RCT) of Early Palliative Care for HCC | unknown | N/A | 72 | The University of Texas Health Science Center, HoustonOTHER | 1 | Apr 27, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT03452553 | Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin | withdrawn | N/A | 0 | Boston Scientific CorporationINDUSTRY | 0 | Apr 21, 2021 | clinicaltrials |
| NCT03706742 | STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention | completed | N/A | 12,386 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 20, 2021 | clinicaltrials |
| NCT03741088 | Study to Evaluate VORTX Rx (Theresa)(Theresa) | completed | N/A | 8 | HistoSonics, Inc.INDUSTRY | 1 | Apr 20, 2021 | clinicaltrials |
| NCT03342677 | Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility | unknown | N/A | 80 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04844112 | CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation | completed | N/A | 139 | Seoul National University HospitalOTHER | 0 | Apr 14, 2021 | clinicaltrials |
| NCT04404647 | Irreversible Electroporation of Unresectable Liver Tumors | withdrawn | N/A | 0 | Ole Thorlacius-Ussing, MD, DMSc, Professor of SurgeryOTHER | 1 | Mar 26, 2021 | clinicaltrials |
| NCT03375281 | Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique | completed | N/A | 140 | Seoul National University HospitalOTHER | 1 | Mar 23, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Feb 11, 2022source: clinicaltrials